Alpha Cognition Inc.

ACOG Healthcare Biotechnology

Alpha Cognition Inc.’s revenue for fiscal 2025 (year ended December 2025) was $10.2 million. In the quarter to June 2026, revenue grew 267.6%, EPS grew 38.5% and free cash flow fell 109.3%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

8.19 0.26 −3.08%
Market cap
$184.0M
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
2.55
Beneish M
n/a
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
ROE

+8 more TTM periods

(142.30%) (40.68%) (51.74%) (49.53%)
ROA
(85.93%) (31.69%) (43.14%) (38.33%)
ROIC
0.00% 0.00% (542.73%) (144.65%)
Return on Tangible Assets
(56.44%) (29.44%) (40.08%) (40.50%)
Average Days of Receivables
0.00 151.28 120.65 130.95
Free Cash Flow per Share
(0.99) (1.17) (1.40) (1.70)
Free Cash Flow
(15.95) (20.67) (30.37) (37.08)
Other line items

Show all line items

Columns are period end dates